己糖激酶2通过蛋白激酶活性调节星形胶质细胞外泌体生成参与急性缺血性脑损伤
批准号:
82071321
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
银巍
依托单位:
学科分类:
脑血管结构、功能异常及相关疾病
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
银巍
中文摘要
脑卒中严重危害人类健康。星形胶质细胞糖酵解、外泌体参与了脑损伤过程。前期发现,糖酵解酶HK2通过代谢外效应引起神经元损伤和小胶质细胞炎性反应;抑制星形胶质细胞HK2阻断缺氧诱导的外泌体生成,并显著减轻急性脑卒中损伤,表明HK2通过外泌体引起急性缺血性脑损伤。但有待阐明HK2对星形胶质细胞外泌体生成的调节机制。预实验显示HK2结合外泌体脂质生成途径关键酶中性鞘磷脂酶(nSMase),HK2酶活性缺失取消其磷酸化,强烈提示HK2通过蛋白激酶活性直接磷酸化nSMase,促进外泌体生成。本项目拟研究HK2对星形胶质细胞外泌体脂质生成途径的调节,确证HK2直接磷酸化nSMase并鉴定磷酸化修饰位点、分析nSMase激活后对产物神经酰胺和外泌体生成的影响。应用星形胶质细胞HK2基因敲除小鼠确证外泌体脑卒中急性期的损伤作用。这将揭示HK2蛋白激酶相关急性缺血性脑损伤机制,为靶向HK2的药物研发提供依据。
英文摘要
Cerebral stroke is a serious hazard to human health. The glycolysis and exosomes of astrocytes are involved in brain injury. We previously identified the glycolytic enzyme hexokinase 2 (HK2) as a critical damage molecule in acute ischemic stroke, which caused neuronal injury and microglial inflammation via the effects other than metabolic function. The inhibition of HK2 in astrocytes significantly reduced the production of exosomes which selectively induced by hypoxia and alleviated acute ischemic brain injury, indicating HK2 caused brain damages by promoting the biogenesis of astrocytes-derived exosomes. However, the regulatory mechanism of HK2 on astrocytes-derived exosomes remains to be elucidated. Our preliminary experiments have shown that HK2 interacted with the neutral sphingomyelinase (nSMase), the key enzyme in the lipid pathway of exosomes biogenesis, and the absence of HK2 enzymic activity abrogated its phosphorylation. These results strongly suggest that HK2 causes acute ischemic brain injury through directly phosphorylating nSMase via its novel activity of protein kinase and promoting the production and release of astrocyte-derived exosomes. This project majorly aims to study the regulation of HK2 via its protein kinase activity on the lipid pathway of exosomes biogenesis. We will further confirm the direct phosphorylation modification of nSMase by HK2, identify its phosphorylation site, and analyze the production of downstream ceramide and the exosomes after the activation of nSMase. Finally, using astrocyte HK2 gene knockout mice we will confirm the damaging effect of astrocytes-derived exosomes in the acute phase of ischemic stroke. This project will reveal a new pathological mechanism of acute ischemic stroke relate to HK2 protein kinase activity and supply a basis for the development of the drugs targeting HK2.
中风对公共卫生构成重大威胁,对其病理机制的了解不足阻碍了治疗药物的研发。已有报道外泌体参与缺血性中风的损伤和恢复过程,并且增强的糖酵解与外泌体的生物发生有关,但外泌体生成的调节机制在很大程度上仍未得到阐明。在本研究中,我们发现大脑中动脉闭塞(MCAO)显著引起小鼠脑脊液和血浆中外泌体的数量增加。此外,缺氧选择性地诱导星形胶质细胞释放外泌体。通过RNAi筛选,我们鉴定了糖酵解酶己糖激酶2(HK2)是缺氧诱导的星形胶质细胞中外泌体及其其前体腔内囊泡(ILVs)产生的关键诱导者。机制研究显示,HK2并不影响ILVs的溶酶体降解,HK2结合并磷酸化激活外泌体脂质生物合成途径中的关键酶即中性鞘磷脂酶1(nSMase1)。对星形胶质细胞外泌体的效应分析显示,缺氧诱导的星形胶质细胞外泌体破坏了脑血管内皮紧密连接蛋白。星形胶质细胞中HK2的选择性敲低显著减少了MCAO诱导的外泌体释放,并减轻了急性缺血性卒中损伤。此外,应用HK2酶活性抑制剂氯尼达明减轻急性缺血性脑卒中损伤,并且应用抑制HK2表达的小分子化合物TRIOL,可减轻谷氨酸引起的有氧糖酵解增强,进而减轻急性缺血性脑卒中和脑实质出血性脑卒中损伤。总之,本项目揭示了HK2通过其蛋白激酶活性在促进星形胶质细胞衍生的外泌体产生中的非代谢作用,并进一步鉴定了HK2在多种脑卒中模型中的损伤作用,为开发针对HK2治疗中风的治疗药物提供了实验依据。
糖酵解酶HK2转录调节IL-6促进缺血性卒
中炎性脑损伤
-
批准号:--
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:银巍
-
依托单位:
糖酵解关键酶HK2在缺血性脑卒中的神经元损伤新角色
-
批准号:81773711
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2017
-
负责人:银巍
-
依托单位:
新型神经保护剂YC-6预防急性高原病的非人灵长类动物多组学研究
-
批准号:81470162
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2014
-
负责人:银巍
-
依托单位:
泛素相互作用蛋白KIAA0280的基因敲除及其对神经元凋亡信号通路的调控
-
批准号:30700202
-
项目类别:青年科学基金项目
-
资助金额:15.0万元
-
批准年份:2007
-
负责人:银巍
-
依托单位:
国内基金
海外基金